Changpeng Zhao–backed YZi Labs has sharply criticized CEA Industries Inc. after the Nasdaq-listed company adopted a poison pill and amended its bylaws. This escalated a fast-moving governance battle that now threatens to reshape control of one of the largest publicly disclosed BNB treasury vehicles in the United States. YZi Labs Calls Out CEA Over “Stockholder-Unfriendly” Moves In a statement posted on X, YZi Labs said it was “disappointed” by what it described as stockholder-unfriendly actions designe ...

Expresses Disappointment in the Board’s Apparent Focus on Entrenchment Rather Than Stockholder Interests Calls on the Board to Avoid Further Manipulative Behavior and to Guarantee a Free and Fair Director Nomination and Election Process Rejects False Claim that the Company Has Never Considered Alternative Tokens ROAD TOWN, British Virgin Islands, Jan. 05, 2026 (GLOBE NEWSWIRE) -- YZILabs Management Ltd. (“YZi”, “we”, “our”), a significant stockholder of CEA Industries Inc. (NASDAQ: BNC) (“BNC” or the “Compa ...

Plantro Cites Materially Deteriorating Financial Results, Sale of Credas, Lack of Board Engagement, and Looming Debt Default Plantro to Evaluate Ownership Position in Dye & Durham SAINT HELIER, Jersey, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Plantro Ltd. ("Plantro") one of the largest shareholders of Dye & Durham Limited ("Dye & Durham" or the "Company") (DND: TSX) today, formally withdrew its September 24, 2025 proposal to acquire the Company for total consideration valued at $10.25 per share (the "Proposal"). S ...